How to improve translatability and clinical relevance of preclinical studies in rheumatoid arthritis
Immunology
.
2024 Mar;171(3):440-443.
doi: 10.1111/imm.13746.
Epub 2023 Dec 26.
Authors
George D Kalliolias
1
2
3
,
Efthimia K Basdra
4
,
Athanasios G Papavassiliou
4
Affiliations
1
Arthritis & Tissue Degeneration, Hospital for Special Surgery, New York, New York, USA.
2
Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
3
Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
4
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
PMID:
38148686
DOI:
10.1111/imm.13746
No abstract available
MeSH terms
Arthritis, Rheumatoid*
Clinical Relevance*
Humans
Risk Factors